NCT01340183View on ClinicalTrials.gov

Clinical Study Assessing the Safety, Tolerability, and Pharmacokinetics of Intravenous AZD5099 in Healthy Subjects

PHASE1SuspendedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Healthy
Interventions
DRUG

AZD5099

IV Dose

DRUG

Placebo

IV Dose

Trial Locations (1)

Unknown

Research Site, Glendale

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY